Pages that link to "Item:Q2637396"

The following pages link to A model for the emergence of drug resistance in the presence of asymptomatic infections (Q2637396):

Displaying 14 items.

• An exploration of the role of asymptomatic infections in the epidemiology of dengue viruses through susceptible, asymptomatic, infected and recovered (SAIR) models (Q1752526) (← links)
• Dynamics of an SVEIRS epidemic model with vaccination and saturated incidence rate (Q1794703) (← links)
• Estimating functional parameters for understanding the impact of weather and government interventions on COVID-19 outbreak (Q2080764) (← links)
• Global stability of SAIRS epidemic models (Q2113895) (← links)
• Analysis of an epidemiological model with age of infection, vaccination, quarantine and asymptomatic transmission (Q2681791) (← links)
• Impacts of Game-Theoretic Activation on Epidemic Spread over Dynamical Networks (Q5019799) (← links)
• The Role of Asymptomatic Infections in the COVID-19 Epidemic via Complex Networks and Stability Analysis (Q5024051) (← links)
• Dynamics in a simple evolutionary-epidemiological model for the evolution of an initial asymptomatic infection stage (Q5073064) (← links)
• Nonlinear dynamics of an epidemic compartment model with asymptomatic infections and mitigation (Q5875867) (← links)
• Global stability of an SAIRS epidemic model with vaccinations, transient immunity and treatment (Q6100923) (← links)
• Threshold dynamics of SAIRS epidemic model with semi‐Markov switching (Q6143555) (← links)
• An explicit formula for minimizing the infected peak in an SIR epidemic model when using a fixed number of complete lockdowns (Q6152789) (← links)
• A multi-strain model with asymptomatic transmission: application to COVID-19 in the US (Q6174200) (← links)
• Global stability of multi‐group SAIRS epidemic models (Q6185420) (← links)